Cristina Mirotti, Luciana Renovato­ Martins, Mariana Du Rocher­Silva, B？rbara Dudenhoeffer­Carneiro, Ana Carolina Soares, Felipe Khandoker Asiqur Rahaman Hasan, Mahbub Muresan, Anca Raluca Kwon, Oh­Seung Son, Junghyun John Pereira, Henrique Marcelo Gualberto 2024-01-12T02:31:54Z 2024-01-12T02:31:54Z 2022-11-24 2023-03 1942-7603 https://pubs.kist.re.kr/handle/201004/75788 Blood transfusion is performed by cheating athletes to rapidly increase oxygen delivery to exercise muscles and enhance their performance. This method is banned by the World Anti-doping Agency (WADA). Heterologous or allogenic blood transfusion happens when blood from a different person is transfused. The method used to detect this type of doping is based on flow cytometry, by identifying variations in blood group minor antigens present on the red blood cells' surface. Transfusion practices have regained interest since the introduction of human recombinant erythropoietin detection method. It has been reported that the number of occurrences of two athletes sharing an identical phenotype in the same sport was five times higher than the theoretical populational probability. The present work describes the prevalence of 10 erythrocytes surface antigens in a population of 261 athletes from all five continents. The matching phenotype per sport is also described. English John Wiley & Sons Ltd. Minor red blood cell antigen phenotyping of athletes sampled in international competitions Article 10.1002/dta.3402 1 Drug Testing and Analysis, v.15, no.3, pp.292 - 298 Drug Testing and Analysis 15 3 292 298 N scie scopus 000887986200001 Biochemical Research Methods Chemistry, Analytical Pharmacology & Pharmacy Biochemistry & Molecular Biology Chemistry Pharmacology & Pharmacy Article; Early Access flow cytometry homologous blood transfusion red blood cell antigens athletes blood doping